Pakistan is a culturally-rich South Asian country with a vibrant population of nearly 250 million. Lahore, the country’s second largest city by population, is the provincial capital of Punjab. Residents of Lahore are proverbially famous for their dynamic and lively nature. However, the rising number of cancer patients in the city is alarming. In this context, presence of the Institute of Nuclear Medicine and Oncology Lahore, INMOL, is nothing short of a blessing.
INMOL hospital began its operations on April 10, 1984. Over the years, the hospital has significantly enhanced its capacity, facilities, and infrastructure. Today, with the availability of 100 beds and more than 250 dedicated staff members including doctors, scientists, engineers, nurses and paramedics, INMOL provides state-of-the-art diagnostic and treatment facilities for cancer patients, all under one roof.
The Division of Nuclear Medicine and PET-CT offers the largest volume and variety of top-notch services for diagnosing not only cancer but also non-malignant diseases such as bone, cardiac, thyroid, and renal disorders. Equipped with two SPECT gamma cameras, two SPECT-CT gamma cameras, and two PET-CT machines, this division has the honour of being the first and the only facility, not only in the country but also in the region, to have acquired two highly advanced and sophisticated machines including the CZT whole body SPECT-CT and Digital PET-CT as mentioned above. This division also has the distinction of being the leader in Theranostics in Pakistan, offering Lutetium-177 therapy for advanced prostate cancer and neuroendocrine tumors since 2017. Last year, nearly 30,000 patients were served at nuclear medicine division.
The Oncology Division plays a pivotal role in the hospital. New patients are received at the walk-in clinic, which functions as a Filter Clinic and around 18000 patients were screened at walk in clinic last year. More than 8,000 new cancer patients were registered at the hospital last year while 84000 patients visited for the follow up.
Notably, INMOL is the only hospital among the 21 Pakistan Atomic Energy Commission Cancer Hospitals that treats blood cancer, specifically leukemia in adults and children.
Chemotherapy is administered at INMOL wards and chemo bay, where almost 150 chemo sessions are conducted daily.
Every Saturday, a multidisciplinary team, led by the Director of INMOL, meets at the tumour board to make critical decisions regarding complicated cases.
The Radiotherapy Division is one of the busiest at INMOL hospital. A dedicated CT simulator is installed for advanced radiotherapy simulation. The division boasts three fully functional Linear Accelerators treating over 300 patents daily. In addition, True Beam, the latest state of the art radiation machine is expected to be installed in the next 3 months. INMOL is also equipped with HDR brachytherapy system, treating over 300 patients daily.
More than 62,000 fractions of radiation were administered to nearly 6,000 patients last year.
Similarly, the patient influx at Radiology Division was recorded over 18,000.
The Radiology Division is equipped with a CT scanner, a 1.5 Tesla MRI, Digital Mammography, Digital X-ray, and Ultrasound machines. This division plays a vital role in the screening, diagnosis, and follow-up of cancer patients.
The Paediatric Haematological Malignancies Ward does a marvellous job at INMOL, treating children above five years old who are suffering from blood cancer. INMOL is honoured to host the only such facility among all Pakistan Atomic Energy Commission cancer hospitals.
The hospital is accredited by the College of Physicians and Surgeons Pakistan for postgraduate training in five disciplines of medicine i e. nuclear medicine, radiation oncology, clinical hematology, medical oncology, and radiology; which is a significant honour.
The Clinical Lab at INMOL is equipped with a PCR machine, biochemistry analysers, cell separators, RIA analyser, and hematology analysers. INMOL also houses a fully functional blood bank facility.
The Radiopharmacy Division at INMOL produces radionuclides used for PET/CT scans. The hospital features a Cyclotron with a Hot lab and Quality Control lab for radionuclide production.
The Biomedical and Engineering Division is the backbone of the hospital, ensuring that all vital equipment is fully functional 24/7.
INMOL has a longstanding history of international collaboration, especially with the International Atomic Energy Agency (IAEA). The hospital has the proud distinction of being declared the Referral Centre as well as the Centre of Excellence for the Asia Pacific region by the agency. Moreover, INMOL has completed over 100 projects under the umbrella of IAEA including Technical Cooperation projects, RCA projects and national projects. Adding another feather in its cap, INMOL won the RCA Award of IAEA in 2022. Besides this recognition, many success stories of INMOL projects have made up for the mark of being published in the IAEA Bulletin.
Besides fulfilling its unwavering commitment to serving ailing humanity, INMOL hospital is looking for the next level of engagement with IAEA under the visionary ‘Rays of Hope’ program.
Pakistan is a culturally-rich South Asian country with a vibrant population of nearly 250 million. Lahore, the country’s second largest city by population, is the provincial capital of Punjab. Residents of Lahore are proverbially famous for their dynamic and lively nature. However, the rising number of cancer patients in the city is alarming. In this context, presence of the Institute of Nuclear Medicine and Oncology Lahore, INMOL, is nothing short of a blessing.
INMOL hospital began its operations on April 10, 1984. Over the years, the hospital has significantly enhanced its capacity, facilities, and infrastructure. Today, with the availability of 100 beds and more than 250 dedicated staff members including doctors, scientists, engineers, nurses and paramedics, INMOL provides state-of-the-art diagnostic and treatment facilities for cancer patients, all under one roof.
The Division of Nuclear Medicine and PET-CT offers the largest volume and variety of top-notch services for diagnosing not only cancer but also non-malignant diseases such as bone, cardiac, thyroid, and renal disorders. Equipped with two SPECT gamma cameras, two SPECT-CT gamma cameras, and two PET-CT machines, this division has the honour of being the first and the only facility, not only in the country but also in the region, to have acquired two highly advanced and sophisticated machines including the CZT whole body SPECT-CT and Digital PET-CT as mentioned above. This division also has the distinction of being the leader in Theranostics in Pakistan, offering Lutetium-177 therapy for advanced prostate cancer and neuroendocrine tumors since 2017. Last year, nearly 30,000 patients were served at nuclear medicine division.
The Oncology Division plays a pivotal role in the hospital. New patients are received at the walk-in clinic, which functions as a Filter Clinic and around 18000 patients were screened at walk in clinic last year. More than 8,000 new cancer patients were registered at the hospital last year while 84000 patients visited for the follow up.
Notably, INMOL is the only hospital among the 21 Pakistan Atomic Energy Commission Cancer Hospitals that treats blood cancer, specifically leukemia in adults and children.
Chemotherapy is administered at INMOL wards and chemo bay, where almost 150 chemo sessions are conducted daily.
Every Saturday, a multidisciplinary team, led by the Director of INMOL, meets at the tumour board to make critical decisions regarding complicated cases.
The Radiotherapy Division is one of the busiest at INMOL hospital. A dedicated CT simulator is installed for advanced radiotherapy simulation. The division boasts three fully functional Linear Accelerators treating over 300 patents daily. In addition, True Beam, the latest state of the art radiation machine is expected to be installed in the next 3 months. INMOL is also equipped with HDR brachytherapy system, treating over 300 patients daily.
More than 62,000 fractions of radiation were administered to nearly 6,000 patients last year.
Similarly, the patient influx at Radiology Division was recorded over 18,000.
The Radiology Division is equipped with a CT scanner, a 1.5 Tesla MRI, Digital Mammography, Digital X-ray, and Ultrasound machines. This division plays a vital role in the screening, diagnosis, and follow-up of cancer patients.
The Paediatric Haematological Malignancies Ward does a marvellous job at INMOL, treating children above five years old who are suffering from blood cancer. INMOL is honoured to host the only such facility among all Pakistan Atomic Energy Commission cancer hospitals.
The hospital is accredited by the College of Physicians and Surgeons Pakistan for postgraduate training in five disciplines of medicine i e. nuclear medicine, radiation oncology, clinical hematology, medical oncology, and radiology; which is a significant honour.
The Clinical Lab at INMOL is equipped with a PCR machine, biochemistry analysers, cell separators, RIA analyser, and hematology analysers. INMOL also houses a fully functional blood bank facility.
The Radiopharmacy Division at INMOL produces radionuclides used for PET/CT scans. The hospital features a Cyclotron with a Hot lab and Quality Control lab for radionuclide production.
Pakistan is a culturally-rich South Asian country with a vibrant population of nearly 250 million. Lahore, the country’s second largest city by population, is the provincial capital of Punjab. Residents of Lahore are proverbially famous for their dynamic and lively nature. However, the rising number of cancer patients in the city is alarming. In this context, presence of the Institute of Nuclear Medicine and Oncology Lahore, INMOL, is nothing short of a blessing.
INMOL hospital began its operations on April 10, 1984. Over the years, the hospital has significantly enhanced its capacity, facilities, and infrastructure. Today, with the availability of 100 beds and more than 250 dedicated staff members including doctors, scientists, engineers, nurses and paramedics, INMOL provides state-of-the-art diagnostic and treatment facilities for cancer patients, all under one roof.
The Division of Nuclear Medicine and PET-CT offers the largest volume and variety of top-notch services for diagnosing not only cancer but also non-malignant diseases such as bone, cardiac, thyroid, and renal disorders. Equipped with two SPECT gamma cameras, two SPECT-CT gamma cameras, and two PET-CT machines, this division has the honour of being the first and the only facility, not only in the country but also in the region, to have acquired two highly advanced and sophisticated machines including the CZT whole body SPECT-CT and Digital PET-CT as mentioned above. This division also has the distinction of being the leader in Theranostics in Pakistan, offering Lutetium-177 therapy for advanced prostate cancer and neuroendocrine tumors since 2017. Last year, nearly 30,000 patients were served at nuclear medicine division.
The Oncology Division plays a pivotal role in the hospital. New patients are received at the walk-in clinic, which functions as a Filter Clinic and around 18000 patients were screened at walk in clinic last year. More than 8,000 new cancer patients were registered at the hospital last year while 84000 patients visited for the follow up.
Notably, INMOL is the only hospital among the 21 Pakistan Atomic Energy Commission Cancer Hospitals that treats blood cancer, specifically leukemia in adults and children.
Chemotherapy is administered at INMOL wards and chemo bay, where almost 150 chemo sessions are conducted daily.
Every Saturday, a multidisciplinary team, led by the Director of INMOL, meets at the tumour board to make critical decisions regarding complicated cases.
The Radiotherapy Division is one of the busiest at INMOL hospital. A dedicated CT simulator is installed for advanced radiotherapy simulation. The division boasts three fully functional Linear Accelerators treating over 300 patents daily. In addition, True Beam, the latest state of the art radiation machine is expected to be installed in the next 3 months. INMOL is also equipped with HDR brachytherapy system, treating over 300 patients daily.
More than 62,000 fractions of radiation were administered to nearly 6,000 patients last year.
Similarly, the patient influx at Radiology Division was recorded over 18,000.
The Radiology Division is equipped with a CT scanner, a 1.5 Tesla MRI, Digital Mammography, Digital X-ray, and Ultrasound machines. This division plays a vital role in the screening, diagnosis, and follow-up of cancer patients.
The Paediatric Haematological Malignancies Ward does a marvellous job at INMOL, treating children above five years old who are suffering from blood cancer. INMOL is honoured to host the only such facility among all Pakistan Atomic Energy Commission cancer hospitals.
The hospital is accredited by the College of Physicians and Surgeons Pakistan for postgraduate training in five disciplines of medicine i e. nuclear medicine, radiation oncology, clinical hematology, medical oncology, and radiology; which is a significant honour.
The Clinical Lab at INMOL is equipped with a PCR machine, biochemistry analysers, cell separators, RIA analyser, and hematology analysers. INMOL also houses a fully functional blood bank facility.
The Radiopharmacy Division at INMOL produces radionuclides used for PET/CT scans. The hospital features a Cyclotron with a Hot lab and Quality Control lab for radionuclide production.
The Biomedical and Engineering Division is the backbone of the hospital, ensuring that all vital equipment is fully functional 24/7.
INMOL has a longstanding history of international collaboration, especially with the International Atomic Energy Agency (IAEA). The hospital has the proud distinction of being declared the Referral Centre as well as the Centre of Excellence for the Asia Pacific region by the agency. Moreover, INMOL has completed over 100 projects under the umbrella of IAEA including Technical Cooperation projects, RCA projects and national projects. Adding another feather in its cap, INMOL won the RCA Award of IAEA in 2022. Besides this recognition, many success stories of INMOL projects have made up for the mark of being published in the IAEA Bulletin.
Besides fulfilling its unwavering commitment to serving ailing humanity, INMOL hospital is looking for the next level of engagement with IAEA under the visionary ‘Rays of Hope’ program.
Pakistan is a culturally-rich South Asian country with a vibrant population of nearly 250 million. Lahore, the country’s second largest city by population, is the provincial capital of Punjab. Residents of Lahore are proverbially famous for their dynamic and lively nature. However, the rising number of cancer patients in the city is alarming. In this context, presence of the Institute of Nuclear Medicine and Oncology Lahore, INMOL, is nothing short of a blessing.
INMOL hospital began its operations on April 10, 1984. Over the years, the hospital has significantly enhanced its capacity, facilities, and infrastructure. Today, with the availability of 100 beds and more than 250 dedicated staff members including doctors, scientists, engineers, nurses and paramedics, INMOL provides state-of-the-art diagnostic and treatment facilities for cancer patients, all under one roof.
The Division of Nuclear Medicine and PET-CT offers the largest volume and variety of top-notch services for diagnosing not only cancer but also non-malignant diseases such as bone, cardiac, thyroid, and renal disorders. Equipped with two SPECT gamma cameras, two SPECT-CT gamma cameras, and two PET-CT machines, this division has the honour of being the first and the only facility, not only in the country but also in the region, to have acquired two highly advanced and sophisticated machines including the CZT whole body SPECT-CT and Digital PET-CT as mentioned above. This division also has the distinction of being the leader in Theranostics in Pakistan, offering Lutetium-177 therapy for advanced prostate cancer and neuroendocrine tumors since 2017. Last year, nearly 30,000 patients were served at nuclear medicine division.
The Oncology Division plays a pivotal role in the hospital. New patients are received at the walk-in clinic, which functions as a Filter Clinic and around 18000 patients were screened at walk in clinic last year. More than 8,000 new cancer patients were registered at the hospital last year while 84000 patients visited for the follow up.
Notably, INMOL is the only hospital among the 21 Pakistan Atomic Energy Commission Cancer Hospitals that treats blood cancer, specifically leukemia in adults and children.
Chemotherapy is administered at INMOL wards and chemo bay, where almost 150 chemo sessions are conducted daily.
Every Saturday, a multidisciplinary team, led by the Director of INMOL, meets at the tumour board to make critical decisions regarding complicated cases.
The Radiotherapy Division is one of the busiest at INMOL hospital. A dedicated CT simulator is installed for advanced radiotherapy simulation. The division boasts three fully functional Linear Accelerators treating over 300 patents daily. In addition, True Beam, the latest state of the art radiation machine is expected to be installed in the next 3 months. INMOL is also equipped with HDR brachytherapy system, treating over 300 patients daily.
More than 62,000 fractions of radiation were administered to nearly 6,000 patients last year.
Similarly, the patient influx at Radiology Division was recorded over 18,000.
The Radiology Division is equipped with a CT scanner, a 1.5 Tesla MRI, Digital Mammography, Digital X-ray, and Ultrasound machines. This division plays a vital role in the screening, diagnosis, and follow-up of cancer patients.
The Paediatric Haematological Malignancies Ward does a marvellous job at INMOL, treating children above five years old who are suffering from blood cancer. INMOL is honoured to host the only such facility among all Pakistan Atomic Energy Commission cancer hospitals.
The hospital is accredited by the College of Physicians and Surgeons Pakistan for postgraduate training in five disciplines of medicine i e. nuclear medicine, radiation oncology, clinical hematology, medical oncology, and radiology; which is a significant honour.
The Clinical Lab at INMOL is equipped with a PCR machine, biochemistry analysers, cell separators, RIA analyser, and hematology analysers. INMOL also houses a fully functional blood bank facility.
The Radiopharmacy Division at INMOL produces radionuclides used for PET/CT scans. The hospital features a Cyclotron with a Hot lab and Quality Control lab for radionuclide production.
The Biomedical and Engineering Division is the backbone of the hospital, ensuring that all vital equipment is fully functional 24/7.
INMOL has a longstanding history of international collaboration, especially with the International Atomic Energy Agency (IAEA). The hospital has the proud distinction of being declared the Referral Centre as well as the Centre of Excellence for the Asia Pacific region by the agency. Moreover, INMOL has completed over 100 projects under the umbrella of IAEA including Technical Cooperation projects, RCA projects and national projects. Adding another feather in its cap, INMOL won the RCA Award of IAEA in 2022. Besides this recognition, many success stories of INMOL projects have made up for the mark of being published in the IAEA Bulletin.
Besides fulfilling its unwavering commitment to serving ailing humanity, INMOL hospital is looking for the next level of engagement with IAEA under the visionary ‘Rays of Hope’ program.
The Biomedical and Engineering Division is the backbone of the hospital, ensuring that all vital equipment is fully functional 24/7.
INMOL has a longstanding history of international collaboration, especially with the International Atomic Energy Agency (IAEA). The hospital has the proud distinction of being declared the Referral Centre as well as the Centre of Excellence for the Asia Pacific region by the agency. Moreover, INMOL has completed over 100 projects under the umbrella of IAEA including Technical Cooperation projects, RCA projects and national projects. Adding another feather in its cap, INMOL won the RCA Award of IAEA in 2022. Besides this recognition, many success stories of INMOL projects have made up for the mark of being published in the IAEA Bulletin.
Besides fulfilling its unwavering commitment to serving ailing humanity, INMOL hospital is looking for the next level of engagement with IAEA under the visionary ‘Rays of Hope’ program.
Original source: pk